Herde Kevin 4
4 · MARAVAI LIFESCIENCES HOLDINGS, INC. · Filed Nov 16, 2023
Insider Transaction Report
Form 4
Herde Kevin
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2023-10-31$5.83/sh+1,861$10,850→ 93,925 total
Footnotes (1)
- [F1]The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,861 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.